Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_588a9f6f9644c092450c1efd7bf33375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c3c03868c3cbb1941929d9d8bc3f664 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-248 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-835 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-84 |
filingDate |
2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2c193e6fb38b7a112b05c417974ea3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_580731b8035dc2b3f96c664b71288908 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a85e479ab8a0709d14d2cfa2d4ba224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82d579efd2e30924b506ea73e891700a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b0fcf3255d64ae66c106321948c5e09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e1ab3ec72a5e0b9456874a7c7b2bcff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c103d5ee7cce2e6a0baa20b60730b5d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1c6fedfaebe58a8c84fdf01628a9829 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1cc03f37b9ae151b705f03cb3cb2c80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc23d2533a7fa7ca1efefd477bf9a5cb |
publicationDate |
2018-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018122689-A1 |
titleOfInvention |
Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia |
abstract |
Compounds of formula (I) in the capacity of compounds with anti-tumor activity for the treatment of T-cell acute lymphoblastic leukemia (T-ALL). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109293492-A |
priorityDate |
2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |